1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TMOD3 CTRPv2 pan-cancer AAC -0.14 7e-05
mRNA RHOC CTRPv2 pan-cancer AAC -0.16 7e-05
mRNA ZBTB18 CTRPv2 pan-cancer AAC 0.13 7e-05
mRNA RALB CTRPv2 pan-cancer AAC -0.13 7e-05
mRNA FAM129B CTRPv2 pan-cancer AAC -0.15 7e-05
mRNA RPS6KA1 CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA HNRNPUL1 CTRPv2 pan-cancer AAC 0.14 7e-05
mRNA PTRH2 CTRPv2 pan-cancer AAC -0.13 7e-05
mRNA ROBO1 CTRPv2 pan-cancer AAC 0.13 7e-05
mRNA KLHDC3 CTRPv2 pan-cancer AAC 0.14 7e-05
Download CSV